9.93
price up icon6.20%   0.58
after-market アフターアワーズ: 9.93
loading
前日終値:
$9.35
開ける:
$9.45
24時間の取引高:
2.23M
Relative Volume:
0.88
時価総額:
$1.17B
収益:
$2.35B
当期純損益:
$-74.42M
株価収益率:
-10.56
EPS:
-0.94
ネットキャッシュフロー:
$150.93M
1週間 パフォーマンス:
+4.20%
1か月 パフォーマンス:
-7.28%
6か月 パフォーマンス:
-1.68%
1年 パフォーマンス:
-55.25%
1日の値動き範囲:
Value
$9.38
$9.94
1週間の範囲:
Value
$9.34
$10.35
52週間の値動き範囲:
Value
$7.06
$33.48

Evolent Health Inc Stock (EVH) Company Profile

Name
名前
Evolent Health Inc
Name
セクター
Healthcare (1164)
Name
電話
571-389-6000
Name
住所
1812 NORTH MOORE ST, SUITE 1705, ARLINGTON
Name
職員
4,500
Name
Twitter
@EvolentHealth
Name
次回の収益日
2024-11-07
Name
最新のSEC提出書
Name
EVH's Discussions on Twitter

EVH を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Health Information Services icon
EVH
Evolent Health Inc
9.93 1.10B 2.35B -74.42M 150.93M -0.94
Health Information Services icon
VEEV
Veeva Systems Inc
290.41 47.59B 2.86B 780.66M 1.20B 4.72
Health Information Services icon
TEM
Tempus Ai Inc
64.49 10.97B 803.32M -709.10M -212.68M -7.8003
Health Information Services icon
DOCS
Doximity Inc
60.77 11.37B 550.17M 201.35M 232.07M 1.00
Health Information Services icon
HQY
Healthequity Inc
96.04 8.16B 1.15B 96.70M -161.99M 1.09
Health Information Services icon
WAY
Waystar Holding Corp
35.83 6.40B 906.14M -52.62M 89.62M -0.3621

Evolent Health Inc Stock (EVH) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-01-10 開始されました Needham Buy
2024-12-03 繰り返されました BTIG Research Buy
2024-11-08 ダウングレード Stephens Overweight → Equal-Weight
2024-10-11 開始されました KeyBanc Capital Markets Overweight
2024-08-09 アップグレード Truist Hold → Buy
2024-04-22 開始されました Citigroup Buy
2024-03-01 開始されました Oppenheimer Outperform
2024-01-03 開始されました Barclays Overweight
2023-12-06 開始されました JMP Securities Mkt Outperform
2023-10-16 開始されました UBS Buy
2023-04-12 開始されました Stephens Overweight
2022-11-01 開始されました Truist Hold
2022-07-29 開始されました RBC Capital Mkts Outperform
2022-03-30 開始されました Guggenheim Buy
2021-11-18 アップグレード JP Morgan Neutral → Overweight
2021-04-29 再開されました JP Morgan Neutral
2021-01-07 開始されました BTIG Research Buy
2020-07-06 ダウングレード KeyBanc Capital Markets Overweight → Sector Weight
2020-06-05 ダウングレード Goldman Buy → Neutral
2020-06-02 ダウングレード Cantor Fitzgerald Overweight → Neutral
2018-10-05 再開されました Leerink Partners Outperform
2018-06-04 開始されました Piper Jaffray Overweight
2018-04-24 再開されました JP Morgan Neutral
2017-09-20 開始されました KeyBanc Capital Mkts Overweight
2017-06-02 開始されました Robert W. Baird Outperform
2017-03-14 開始されました Oppenheimer Outperform
2017-01-13 アップグレード Wells Fargo Market Perform → Outperform
2016-10-28 再開されました JP Morgan Overweight
2016-08-05 繰り返されました FBR Capital Outperform
2016-07-26 開始されました Jefferies Buy
2016-07-13 繰り返されました FBR Capital Outperform
2016-03-29 開始されました FBR Capital Outperform
2016-01-06 開始されました Canaccord Genuity Buy
2015-06-30 開始されました Goldman Buy
2015-06-30 開始されました JP Morgan Overweight
2015-06-30 開始されました Leerink Partners Outperform
2015-06-30 開始されました Sun Trust Rbsn Humphrey Buy
すべてを表示

Evolent Health Inc (EVH) 最新ニュース

pulisher
Jul 25, 2025

The Analyst Verdict: Evolent Health In The Eyes Of 5 Experts - 富途牛牛

Jul 25, 2025
pulisher
Jul 25, 2025

What drives Evolent Health Inc. stock priceAccelerated investment success - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

What makes Evolent Health Inc. stock attractive to long term investorsMarket-crushing profits - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 25, 2025

Will Evolent Health Inc. stock split in the near futureOverwhelming profit margins - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 24, 2025

How Evolent Health Inc. stock reacts to Fed policy changesJaw-dropping returns - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 24, 2025

What analysts say about Evolent Health Inc. stockHigh-margin investment plays - Autocar Professional

Jul 24, 2025
pulisher
Jul 23, 2025

Elevance Health, EchoStar, Icahn Enterprises, Evolent Health, and The Trade Desk Shares Are Soaring, What You Need To Know - TradingView

Jul 23, 2025
pulisher
Jul 23, 2025

Is Evolent Health Inc. a good long term investmentExceptional market positioning - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

Evolent Health Inc. Stock Analysis and ForecastFree Investment Timing Strategies - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 19, 2025

Truist Financial Maintains Evolent Health(EVH.US) With Buy Rating, Raises Target Price to $16 - 富途牛牛

Jul 19, 2025
pulisher
Jul 18, 2025

Evolent Health, West Pharmaceutical Services, Myriad Genetics, Tandem Diabetes, and Integra LifeSciences Shares Are Falling, What You Need To Know - Yahoo Finance

Jul 18, 2025
pulisher
Jul 17, 2025

Truist Securities Raises Price Target for Evolent Health (EVH) | - GuruFocus

Jul 17, 2025
pulisher
Jul 17, 2025

Evolent Health: Truist Securities Maintains Buy, Raises PT to $16 from $14. - AInvest

Jul 17, 2025
pulisher
Jul 17, 2025

Evolent Health Insiders Added US$1.35m Of Stock To Their Holdings - 富途牛牛

Jul 17, 2025
pulisher
Jul 14, 2025

Evolent Health Announces Q2 Earnings Date and Major Growth Conference Appearance - Stock Titan

Jul 14, 2025
pulisher
Jul 14, 2025

Evolent Health, Inc. (NYSE:EVH) Stock Catapults 35% Though Its Price And Business Still Lag The Industry - simplywall.st

Jul 14, 2025
pulisher
Jul 14, 2025

Evolent To Release Second Quarter 2025 Financial Results on Thursday, August 7, 2025 - Yahoo Finance

Jul 14, 2025
pulisher
Jul 13, 2025

EVH Press Release: Evolent To Release Second Quarter 2025 Financi... - 富途牛牛

Jul 13, 2025
pulisher
Jul 12, 2025

Evolent Health taps David Lim as chief clinical officer - MSN

Jul 12, 2025
pulisher
Jul 11, 2025

U.S. Physical Therapy, Evolent Health, Charles River Laboratories, Moderna, and Intuitive Surgical Shares Are Falling, What You Need To Know - TradingView

Jul 11, 2025
pulisher
Jul 11, 2025

BPAS - FinancialContent

Jul 11, 2025
pulisher
Jul 10, 2025

Evolent adds Dr. David Lim as chief clinical officer, John Way as CFO By Investing.com - Investing.com South Africa

Jul 10, 2025
pulisher
Jul 09, 2025

Evolent Health Appoints Dr. David Lim as Chief Clinical Officer; John Way as CFO, Performance Suite - citybiz

Jul 09, 2025
pulisher
Jul 09, 2025

Evolent adds Dr. David Lim as chief clinical officer, John Way as CFO - Investing.com

Jul 09, 2025
pulisher
Jul 09, 2025

Former OptumHealth CFO Joins Evolent as Healthcare Giant Expands Specialty Care Leadership - Stock Titan

Jul 09, 2025
pulisher
Jul 07, 2025

Evolent Health stock rating reaffirmed at Buy by Truist on managed care trends - Investing.com Canada

Jul 07, 2025
pulisher
Jul 07, 2025

The Top 5 Analyst Questions From Evolent Health’s Q1 Earnings Call - Yahoo Finance

Jul 07, 2025
pulisher
Jul 03, 2025

SUN extends revolver to 2030, upsizes to $2.46B for Parkland deal | EVH SEC FilingForm 4 - Stock Titan

Jul 03, 2025
pulisher
Jul 03, 2025

JMP Maintains Price Target and Market Outperform Rating on Evolent Health (EVH) - Insider Monkey

Jul 03, 2025
pulisher
Jun 30, 2025

Evolent Health, Inc.(NYSE: EVH) added to Russell Small Cap Comp Value Index - MarketScreener

Jun 30, 2025

Evolent Health Inc (EVH) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Evolent Health Inc (EVH) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
McCarthy Daniel Joseph
PRESIDENT
Mar 06 '25
Buy
9.01
11,040
99,470
389,004
Jelinek Richard M
Director
Mar 07 '25
Buy
9.12
30,000
273,750
15,000
GRUA PETER J
Director
Mar 06 '25
Buy
9.01
11,040
99,470
18,749
Blackley Seth
Chief Executive Officer
Mar 06 '25
Buy
9.01
55,225
497,577
762,217
Springstubb Brendan B
Director
Mar 07 '25
Buy
9.27
15,000
139,050
26,842
Glass Russell Monroe
Director
Mar 06 '25
Buy
9.27
5,400
50,058
14,272
KECK KIM
Director
Mar 07 '25
Buy
9.44
10,540
99,498
39,522
Barbarosh Craig A.
Director
Mar 06 '25
Buy
8.81
2,000
17,620
31,956
Springstubb Brendan B
Director
Mar 04 '25
Buy
8.75
5,000
43,750
11,842
$21.18
price down icon 0.21%
$11.09
price up icon 1.00%
$19.70
price up icon 0.03%
$45.77
price down icon 0.46%
$20.53
price down icon 0.63%
health_information_services WAY
$35.83
price down icon 3.11%
大文字化:     |  ボリューム (24 時間):